Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BLUEWAVE Technologies is a private healthtech and medical device company developing and marketing the BLUEWAVE disinfection system for orthotic, prosthetic, and other personal medical devices. Its core product is a fully enclosed, liquid-free device that uses activated oxygen and a proprietary vacuum infusion process to deodorize items and reduce bacteria, viruses, and fungi without water, detergents, or added chemicals. The company primarily serves orthotic and prosthetic clinics and adjacent rehabilitation settings through device sales, consumables, and a recurring service/subscription model. BLUEWAVE appears to be a commercial-stage medical device business rather than a therapeutics developer, with no evidence of a drug pipeline or clinical-stage pharmaceutical assets. Its positioning is centered on infection control, patient comfort, and workflow efficiency in outpatient healthcare environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BLUEWAVE Technologies.